Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Rapid Responses to:
|
|
Rapid Responses published:
|
|
|||
|
Godon Rafool, Medical Doctor Winter Haven,FL 33881 USA
Send response to journal:
|
There sre at least 2 circumstances that a PSA is valuable in the under 50. Any patient who has a first degree relative with prostate cancer should have a PSA test done in their 40'. They should also have a DRE done as well. Another and very important reason, a recent study done by Hans Lilja,MD,PhD. an attending research clinical chemist at Memorial Sloan- Kittering Cancer Center in New York detailed how a single PSA test given to more than 21,000 men in there early 40's was highly predictive of their developing advanced cancers that developed over a 25 year period were associated with PSA values in the 80th percentile or greater among men between the ages of 44 and 50. His study showed that a PSA of 0.5ng/ml at the time of sampling had a 2% liklihood of developing advanced prostate cancer years later. However if the original PSA was 2 ng/ml or higher the risk of advanced cancer was 12%. This study will provide physicians with a better tool to decide what course of treatment should be offered to the patient with early diagnosed proatate cancer. "PSA screening is the most common way that prostate cancer is detected in the United States." This quote is not only mine but Jareck L. Mostwin medical editor of the Johns Hopkins prostate Bulletin. Competing interests: None declared |
|||